How Fedegari Supported MCCPDC’s Vision for Accessible, Affordable Medicines

High drug prices have long created barriers for patients across the United States. Mark Cuban Cost Plus Drug Company, known for its cost transparency and patient focused mission, set out to address this challenge by building a flexible sterile fill-finish facility in Dallas, TX. The facility was designed to manufacture low-cost versions of high-cost generic medicines while responding more quickly to shortages that affect patients nationwide.

To achieve this vision, MCCPDC selected Fedegari as its partner for washing and sterilization technologies. The partnership was shaped by collaboration, open communication, and a shared dedication to reducing the cost of essential drugs.

A Collaborative Partnership That Put MCCPDC’s Mission First

From the beginning, MCCPDC required equipment that supported efficient production, sustainability, space optimization, and lower operating costs. Fedegari worked closely with MCCPDC leadership to understand the company’s operational goals and the unique needs of its new facility.

These conversations led to the adoption of the Fedegari FOWS  Washer – Sterilizer, which combined two essential processes into a single integrated unit.

MCCPDC CEO Alex Oshmyansky, MD, PhD, emphasized the importance of saving space and creating cost efficiencies:

“Fedegari unique product offerings allowed us to maximize the space available. This enabled us to be more efficient and effective in our pharma manufacturing.”

Why the Fedegari FOWS Was the Right Choice

MCCPDC’s Dallas facility was engineered for flexibility and small batch production. The FOWS Washer – Sterilizer supported this approach through several advantages.

• A Smaller Equipment Footprint: By combining washing and sterilization, the unit conserved valuable floor space and supported a highly adaptable layout.
• Lower Operating Costs: With fewer machines to maintain, validate, and operate, MCCPDC reduced overall energy use and resource consumption, which directly supported its cost plus pricing model.
• Shorter Processing Time: The integrated workflow improved efficiency and helped accelerate the availability of drugs that are often in short supply.
• Environmental Benefits: The use of one multipurpose system decreased water use, reduced energy consumption, and supported more sustainable operations.

Oshmyansky added:

“We chose Fedegari’s washer – sterilizer as it combines two processes in one machine. This multipurpose equipment reduces our operating costs while combining the high-performance of a steam sterilizer into a jet washer. Fedegari is a proactive and efficient partner, especially with regard to our business activities and our work with regulators.”

A Shared Commitment to Improving Patient Access

Fedegari and MCCPDC share the belief that technology and innovation should be used to improve lives and expand access to essential treatments.

Fedegari President Giuseppe Fedegari noted:

“We enthusiastically supported Mark Cuban Cost Plus Drug Company in its vision to save more lives through cost effective manufacturing of life enhancing drugs. Dramatically reducing the production costs of small drug batches inspired us to continue innovating.”

For Fedegari, this project represented more than equipment integration. It was an opportunity to contribute meaningfully to public health in the United States.

A Blueprint for the Future of Sterile Manufacturing

The MCCPDC project showed that sterile drug manufacturing can be flexible, cost efficient, and responsive to real-world needs. The Dallas facility proved that with the right technology and strong collaboration, high quality drugs can be produced at a fraction of traditional costs.

Fedegari’s role reinforced a broader message for U.S. manufacturers: partnering with the right experts makes it possible to streamline washing and sterilization, reduce operating expenses, and build facilities that are both compliant and efficient.

This partnership demonstrates how innovation and teamwork can reshape the industry. Fedegari remains committed to supporting pharmaceutical and biotechnology teams with reliable, sustainable, and cost effective solutions.

If your organization is exploring ways to modernize production or improve efficiency, the Fedegari Americas team is ready to help.